PRM-151

recombinant human pentraxin-2 · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PRM-151, covering 2014-08-07 to 2024-05-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis [Phase 3]

See pricing